Full-Time

Channel and Strategic Partnerships Director

Ketryx

Ketryx

51-200 employees

SaaS platform for regulated medical software

No salary listed

No H1B Sponsorship

Boston, MA, USA

Hybrid

Category
Business & Strategy (1)
Required Skills
Atlassian
Forecasting
Product Management
AWS
Marketing

Get referred to Ketryx

Find people who can refer or advise you

Requirements
  • Must have 5+ years demonstrated experience in strategic business development, technology alliances, product management/marketing, technical/solution marketing or technical sales enablement role at a SaaS technology provider. Mix of start-up and public company experience preferred
  • Proven track record of closing high-impact partnerships with large enterprise platforms (e.g., Atlassian, AWS, etc.) and driving measurable revenue through joint go-to-market and co-selling motions
  • Strong entrepreneurial drive and ownership mindset; you thrive in ambiguity, self-initiate new motions, and build systems where none exist
  • Successful track record of designing partnership structures and revenue-sharing agreements that create aligned incentives and real commercial outcomes
  • Highly analytical and strategic thinker with the ability to develop partner scoring rubrics, co-selling frameworks, and tiering models that scale
  • Comfortable building pricing models, incentive plans, and forecasting partner-sourced revenue in collaboration with RevOps and finance
  • Excellent communicator and storyteller, with strong marketing sensibility
  • Experience building and executing partner briefs, co-marketing campaigns, and enablement materials that drive engagement and lead flow
  • Comfortable working cross-functionally with legal, product, sales, and marketing to bring structured partner programs to life, from contracting to launch
Responsibilities
  • Build and launch Ketryx’s partner program from the ground up including tiering, incentives, onboarding flows, and co-sell enablement across both technology and consulting partners
  • Identify, recruit, and activate high-leverage partners; Own the structuring and negotiation of partnership agreements in collaboration with legal and executive leadership
  • Develop and operationalize co-selling motions defining how we work with partners to share leads, align on deals, and accelerate sales through trusted third parties
  • Drive measurable partner-sourced and partner-influenced pipeline by working closely with Sales and RevOps to attribute impact, optimize efforts, and hit pipeline contribution goals
  • Manage and grow long-term partner relationships through maintaining regular touchpoints, facilitating joint planning, and ensuring partner success through clear incentives and engagement models
  • Collaborate cross-functionally with Sales, Marketing, and Product to align messaging, surface integration opportunities, and ensure partners are equipped with the right tools and stories
  • Track and report on partner performance

Ketryx offers a SaaS Connected Lifecycle Management platform for regulated medical software. It guides the full lifecycle from planning through verification and maintenance, ensuring compliance with FDA, IEC 62304, GMP, ISO 13485, and CFR 21 Part 11. The platform integrates traceability, documentation, Jira, and SBOM management to streamline development, quality, and compliance. It targets MedTech teams from startups to large enterprises, aiming to reduce compliance risk and development costs while speeding time to market.

Company Size

51-200

Company Stage

Series B

Total Funding

$57.1M

Headquarters

Cambridge, Massachusetts

Founded

2021

Get referred to Ketryx

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • $39M Series B from Transformation Capital fuels 2025-2026 enterprise expansion.
  • Platform impacts 20M+ patients, trusted by RadNet, HeartFlow, and Fortune 500s.
  • Hired Zack Jha as VP Sales from PTC/AWS to accelerate global customer acquisition.

What critics are saying

  • PTC Codebeamer captures large MedTech firms with established IEC 62304 compliance.
  • Greenlight Guru dominates eQMS with FDA clearance and 10-year network effects.
  • FDA AI/ML Action Plan forces Ketryx AI revalidation, delaying deployments by Q3 2026.

What makes Ketryx unique

  • Ketryx's AI agents automate 90% of documentation for FDA-compliant medical software.
  • Real-time traceability integrates Jira, Git, and TestRail without manual matrices.
  • Validated AI handles regulated AI for MedTech, unlike traditional ALM tools.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Unlimited Paid Time Off

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

6%

2 year growth

13%
VentureFizz
Sep 30th, 2025
Hiring Unlocked: Ketryx Event Video - Company Details, Jobs, Culture, and More

Recently, Ketryx announced a $39M Series B round of funding led by Transformation Capital, with participation from existing investors including Lightspeed Venture Partners, MIT's E14 Fund, Ubiquity Ventures, and 53 Stations.

FinSMEs
Sep 4th, 2025
Ketryx Raises $39M in Series B Funding

Ketryx, a Cambridge, MA-based AI-powered compliance platform helping life sciences companies ship safer products faster, raised $39M in Series B funding

PR Newswire
Sep 4th, 2025
Ketryx Raises $39M Series B Round to Power the Future of Regulated Artificial Intelligence for Life Sciences

Ketryx raises $39M Series B round to power the future of regulated artificial intelligence for life sciences.

SiliconANGLE Media
Sep 4th, 2025
Ketryx raises $39M to help medical device makers ship safer products faster

Ketryx Corp., a company transforming product lifecycle development and compliance for medical device makers with artificial intelligence, today announced it has raised $39 million in a Series B funding round led by Transformation Capital.

TechIntelPro
May 2nd, 2025
Ketryx Launches First Validated AI Agents to Accelerate Safety-Critical Product Development

Ketryx launches first validated AI Agents to accelerate safety-critical product development.